TY - JOUR
T1 - The preferred conformation of the tripeptide Ala-Phe-Ala in water is an inverse γ-turn
T2 - Implications for protein folding and drug design
AU - Motta, Andrea
AU - Reches, Meital
AU - Pappalardo, Lucia
AU - Andreotti, Giuseppina
AU - Gazit, Ehud
PY - 2005/11/1
Y1 - 2005/11/1
N2 - Recent studies have provided evidence that peptides as short as tripeptides do adopt preferred conformations. Here we report that the tripeptide Ala-Phe-Ala (AFA) in aqueous solution preferentially forms an inverse γ-turn. Circular dichroism (CD) indicated the presence of a predominant turn structure, and Fourier transform infrared (FTIR) bands suggested the presence of a γ-turn forming a bifurcated H-bond with the solvent molecules. The high-resolution structure was obtained by a combined use of NMR spectroscopy and calculations. On the basis of 30 unambiguous ROESY-derived distance restraints (including the Hα-NH NOE between Ala1 and Ala3 and a hydrogen bond between the CO group of Ala1 and the NH group of Ala3), calculations clearly demonstrated the presence of an inverse γ-turn centered on Phe2. From NOE data, we estimated a mole fraction for the γ-turn of 0.65. Since for AFA an extended β-strand was also reported [Eker, F., Griebenow, K., Cao, X., Nafie, L. A., and Schweitzer-Stenner, R. (2004) Proc. Natl. Acad. Sci. U.S.A. 101, 10054-10059], we investigated the possibility that γ-turn and β-strand may represent two major conformations. By using a best-fit procedure that calculated experimental NOEs as weighted averages of the effects originating from both structures, we were able to calculate with good accuracy the backbone NOEs at 280 K in terms of the two limiting conformers, yielding a mole fraction for the γ-turn and β-strand conformations of 0.60 and 0.40, respectively, in good agreement with those found by NOE data. The implication of the existence of a preferred conformation by a small structural element is discussed in the context of the nucleation of protein folding events and the design of small peptide and peptidomimetic drugs.
AB - Recent studies have provided evidence that peptides as short as tripeptides do adopt preferred conformations. Here we report that the tripeptide Ala-Phe-Ala (AFA) in aqueous solution preferentially forms an inverse γ-turn. Circular dichroism (CD) indicated the presence of a predominant turn structure, and Fourier transform infrared (FTIR) bands suggested the presence of a γ-turn forming a bifurcated H-bond with the solvent molecules. The high-resolution structure was obtained by a combined use of NMR spectroscopy and calculations. On the basis of 30 unambiguous ROESY-derived distance restraints (including the Hα-NH NOE between Ala1 and Ala3 and a hydrogen bond between the CO group of Ala1 and the NH group of Ala3), calculations clearly demonstrated the presence of an inverse γ-turn centered on Phe2. From NOE data, we estimated a mole fraction for the γ-turn of 0.65. Since for AFA an extended β-strand was also reported [Eker, F., Griebenow, K., Cao, X., Nafie, L. A., and Schweitzer-Stenner, R. (2004) Proc. Natl. Acad. Sci. U.S.A. 101, 10054-10059], we investigated the possibility that γ-turn and β-strand may represent two major conformations. By using a best-fit procedure that calculated experimental NOEs as weighted averages of the effects originating from both structures, we were able to calculate with good accuracy the backbone NOEs at 280 K in terms of the two limiting conformers, yielding a mole fraction for the γ-turn and β-strand conformations of 0.60 and 0.40, respectively, in good agreement with those found by NOE data. The implication of the existence of a preferred conformation by a small structural element is discussed in the context of the nucleation of protein folding events and the design of small peptide and peptidomimetic drugs.
UR - http://www.scopus.com/inward/record.url?scp=27444446525&partnerID=8YFLogxK
U2 - 10.1021/bi050658v
DO - 10.1021/bi050658v
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 16245933
AN - SCOPUS:27444446525
SN - 0006-2960
VL - 44
SP - 14170
EP - 14178
JO - Biochemistry
JF - Biochemistry
IS - 43
ER -